The Jardiance jingle probably rings through your head for several hours after you watch the ad, and that's the point. You remember the ad for "the little pill with a big story to tell." Last year's ad ...

Cardiorenal benefits of empagliflozin in patients with chronic kidney disease continue for up to 12 months after discontinuation but diminish over time. Long-term use may be necessary to maximize ...

In the active trial, patients with chronic kidney disease were randomly assigned to receive either empagliflozin (10 mg once daily) or matching placebo and were followed for a median of 2 years ...

Eli Lilly and Boehringer Ingelheim have changed the terms of their diabetes alliance to focus their energies on developing their big-selling Jardiance pill. Under the terms of the original ...